Federica Invernizzi

Dr. Federica Invernizzi

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2010 in Nature Genetics
Verified
Journal Article
Closed access
THTobias B Haack
Tobias B Haack
KDKatharina Danhauser
Katharina Danhauser
BHBirgit Haberberger
Birgit Haberberger
JHJonathan Hoser
Jonathan Hoser
VSValentina Strecker
Valentina Strecker
PHProkisch Holger
Prokisch Holger

1 December 2004 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
MBM. Bugiani
M. Bugiani
FIFederica Invernizzi
Federica Invernizzi
SAS. Alberio
S. Alberio
EBE. Briem
E. Briem
ELEleonora Lamantea
Eleonora Lamantea
Massimo ZevianiMassimo Zeviani
Massimo Zeviani

24 May 2009 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
Daniele GhezziDaniele Ghezzi
Daniele Ghezzi
PGPaola Goffrini
Paola Goffrini
GUGraziella Uziel
Graziella Uziel
RHRita Horvath
Rita Horvath
TKThomas Klopstock
Thomas Klopstock
Massimo ZevianiMassimo Zeviani
Massimo Zeviani

1 April 2010 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
Daniele GhezziDaniele Ghezzi
Daniele Ghezzi
ISIrina Sevrioukova
Irina Sevrioukova
FIFederica Invernizzi
Federica Invernizzi
CLCostanza Lamperti
Costanza Lamperti
MMMarina Mora
Marina Mora
Massimo ZevianiMassimo Zeviani
Massimo Zeviani

1 January 2014 in The American Journal of Human Genetics
Verified
Journal Article
Open access
SDSabrina Dusi
Sabrina Dusi
LVLorella Valletta
Lorella Valletta
THTobias B. Haack
Tobias B. Haack
YTYugo Tsuchiya
Yugo Tsuchiya
PVPaola Venco
Paola Venco
VTValeria Tiranti
Valeria Tiranti
Neurodegeneration with brain iron accumulation (NBIA) comprises a clinically and genetically heterogeneous group of disorders with progressive extrapyramidal signs and neurological deterioration, characterized by iron accumulation in the basal ganglia. Exome sequencing revealed the presence of recessive missense mutations in COASY, encoding coenzyme A (CoA) synthase in one NBIA-affected subject. A second unrelated individual carrying mutations in COASY was identified by Sanger sequence analysis. CoA synthase is a bifunctional enzyme catalyzing the final steps of CoA biosynthesis by coupling phosphopantetheine with ATP to form dephospho-CoA and its subsequent phosphorylation to generate CoA. We demonstrate alterations in RNA and protein expression levels of CoA synthase, as well as CoA amount, in fibroblasts derived from the two clinical cases and in yeast. This is the second inborn error of coenzyme A biosynthesis to be implicated in NBIA.

5 May 2016 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
EOElisa Onesto
Elisa Onesto
CCClaudia Colombrita
Claudia Colombrita
VGValentina Gumina
Valentina Gumina
MBMaria Orietta Borghi
Maria Orietta Borghi
SDSabrina Dusi
Sabrina Dusi
ARAntonia Ratti
Antonia Ratti
Dysregulation of RNA metabolism represents an important pathogenetic mechanism in both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) due to the involvement of the DNA/RNA-binding proteins TDP-43 and FUS and, more recently, of C9ORF72. A potential link between dysregulation of RNA metabolism and mitochondrial dysfunction is recently emerged in TDP-43 disease models. To further investigate the possible relationship between these two pathogenetic mechanisms in ALS/FTD, we studied mitochondria functionality in human mutant TARDBP(p.A382T) and C9ORF72 fibroblasts grown in galactose medium to induce a switch from a glycolytic to an oxidative metabolism. In this condition we observed significant changes in mitochondria morphology and ultrastructure in both mutant cells with a fragmented mitochondria network particularly evident in TARDBP(p.A382T) fibroblasts. From analysis of the mitochondrial functionality, a decrease of mitochondria membrane potential with no alterations in oxygen consumption rate emerged in TARDBP fibroblasts. Conversely, an increased oxygen consumption and mitochondria hyperpolarization were observed in C9ORF72 fibroblasts in association to increased ROS and ATP content. We found evidence of autophagy/mitophagy in dynamic equilibrium with the biogenesis of novel mitochondria, particularly in mutant C9ORF72 fibroblasts where an increase of mitochondrial DNA content and mass, and of PGC1-α protein was observed. Our imaging and biochemical data show that wild-type and mutant TDP-43 proteins do not localize at mitochondria so that the molecular mechanisms responsible for such mitochondria impairment remain to be further elucidated. For the first time our findings assess a link between C9ORF72 and mitochondria dysfunction and indicate that mitochondria functionality is affected in TARDBP and C9ORF72 fibroblasts with gene-specific features in oxidative conditions. As in neuronal metabolism mitochondria are actively used for ATP production, we speculate that TARDBP and C9ORF72 mutations might trigger cell death by impairing not only RNA metabolism, but also mitochondria activity in ALS/FTD neurons.